Article List

WPRIM Management System> DCMS> The Korean Journal of Internal Medicine> 2014> 29> 1

Volume: 29 Issue: 1

1. Severe influenza treatment guideline.	Page:132—147
2. Cervical spine fracture in advanced ankylosing spondylitis.	Page:131—131
3. Acupuncture needle: an obscure cause of anal pain.	Page:130—130
4. Eosinophilic organ infiltration without eosinophilia or direct parasite infection.	Page:126—129
5. Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation.	Page:123—125
6. Neuropathic truncal pain in patients with type 2 diabetes mellitus relieved by topical cream and nerve block.	Page:120—122
7. Diabetic ketoacidosis as a presenting symptom of complicated pancreatic cancer.	Page:116—119
8. Hypothermia-induced acute kidney injury in an elderly patient.	Page:111—115
9. Spontaneous coronary artery dissection by intravascular ultrasound in a patient with myocardial infarction.	Page:106—110
10. Hepatoduodenal fistula formation following transcatheter arterial chemoembolization and radiotherapy for hepatocellular carcinoma: treatment with endoscopic Histoacryl injection.	Page:101—105
11. Duodenal adenocarcinoma following a neuroendocrine tumor in the duodenum.	Page:96—100
12. Clinical features and prognostic factors of Churg-Strauss syndrome.	Page:85—95
13. Poor agreement between QuantiFERON-TB Gold test and tuberculin skin test results for the diagnosis of latent tuberculosis infection in rheumatoid arthritis patients and healthy controls.	Page:76—84
14. Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary intervention.	Page:66—75
15. Is propofol safe when administered to cirrhotic patients during sedative endoscopy?.	Page:57—65
16. Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.	Page:49—56
17. Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea.	Page:40—48
18. Measurement of antioxidant capacity using the biological antioxidant potential test and its role as a predictive marker of metabolic syndrome.	Page:31—39
19. Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern.	Page:27—30
20. Risks associated with sunitinib use and monitoring to improve patient outcomes.	Page:23—26
21. Oxidative stress, point-of-care test, and metabolic syndrome.	Page:20—22
22. S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis.	Page:12—19
23. Antiangiogenesis therapy: an update after the first decade.	Page:1—11